Mark Sulkowski MD FAASLD is a Professor of Medicine at the Johns Hopkins University School of Medicine in Baltimore, Maryland

Kerry Sivia is a patient advocate living with metabolic dysfunction–associated steatotic liver disease (MASLD/MASH), autoimmune hepatitis, primary biliary cholangitis (PBC), and cirrhosis. Since receiving her diagnoses in 2021, she has become a leading voice for patient-centered advocacy in hepatology care, focusing on multidisciplinary collaboration, health equity, and the lived experience of people affected by liver disease.<br><br>Kerry serves as a Dr. Stephen A.

Susan Horava, a certified health coach, serves as the Director of Ambassador and Lifestyle Management Programs at Liver Education Advocates. After years of battling undiagnosed elevated liver enzymes and debilitating fatigue, an ultrasound revealed her fatty liver disease. This progressed to a diagnosis of metabolic-related cirrhosis. Fueled by resolve, Susan immersed herself in researching metabolic liver disease, embracing the transformative power of whole foods, regular exercise, and quality sleep. She was able to achieve fibrosis regression and a stabilized low MELD score.

Dr. Jonathan Stine is an Associate Professor of Medicine and Public Health Science at Penn State where he serves as the Fatty Liver Program Director and Liver Center Research Director. As an internationally recognized liver expert with a research and clinical focus on metabolic dysfunction-associated steatotic liver disease (MASLD), he has authored more than 125 peer-reviewed papers, including multinational consensus guidelines for the American College of Sports Medicine and Exercise and Sports Science Australia, and has lectured across the United States and Europe. Dr.

Esther Fasanmi is a clinical pharmacist responsible for providing pharmacotherapeutic care for those living with HIV and viral hepatitis. She is a preceptor for family medicine medical residents, pharmacy residents, and students and serves as a clinical expert for other healthcare providers. Dr. Fasanmi received her Doctorate of Pharmacy from Texas Southern University College of Pharmacy and Health Sciences.

Anthony Derencius is a Physician Assistant and Sub-Investigator at Pinnacle Clinical Research in San Antonio, Texas. His work experience includes clinical duties and care in general Gastroenterology, and both oupatient/inpatient Hepatology and Transplant Hepatology. He was selected for a 2018 AASLD Foundation NP/PA Clinical Hepatology Fellowship Award and is an active member of both the Hepatology Associates Committee and Special Interest Group.

Nancy Reau, MD, is Professor of Internal Medicine, Richard B. Capps Chair of Hepatology, Associate Director of Solid Organ Transplantation, and Section Chief of Hepatology at Rush University Medical Center in Chicago, IL. She received her medical degree from The Ohio State University College of Medicine in Columbus, where she completed a residency and fellowship in gastroenterology/hepatology followed by a second fellowship in advanced transplant hepatology at Johns Hopkins Hospital in Baltimore, MD.

Dr. James Park is a Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He serves as Co-Director of the Northwell Center for Liver Disease and Transplantation and Chief of the Division of Hepatology, Medicine Service Line at Northwell Health. Dr. Park earned his medical degree from the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, followed by an internal medicine residency at NYU Medical Center.

HoChong Gilles obtained her master's in nursing from Virginia Commonwealth University in 1999 and her Doctorate in Nursing Practice from the University of Virginia in 2018. With over 25 years of experience as a Nurse Practitioner in Hepatology, she serves as the Clinical Program Director for the Gastroenterology and Hepatology Division and Assistant Director of GI Research in Richmond, Virginia. Her clinical and research interests include viral hepatitis, MASLD, portal hypertension and hepatocellular carcinoma.

Dawn Drazek is a hepatology nurse practitioner with Atrium Health Liver Care & Transplant. Dawn is an Associate Fellow of the AASLD (AF-AASLD), former AASLD NP/PA Clinical Hepatology Fellowship awardee, and was awarded as an AASLD Mid-Career Hepatology Scholar. She has been practicing in liver disease and transplant since 2005 as a liver transplant coordinator at the Penn Transplant Institute and as a Hepatology nurse practitioner with Atrium Health since 2015.